- Home
- LXEH vs ADVB Comparison
LXEH vs ADVB Comparison
Compare LXEH & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- ADVB
- Stock Information
- Founded
- LXEH 2001
- ADVB 2014
- Country
- LXEH China
- ADVB United States
- Employees
- LXEH N/A
- ADVB N/A
- Industry
- LXEH Other Consumer Services
- ADVB Medical Specialities
- Sector
- LXEH Real Estate
- ADVB Health Care
- Exchange
- LXEH Nasdaq
- ADVB Nasdaq
- Market Cap
- LXEH 25.1M
- ADVB 20.8M
- IPO Year
- LXEH 2020
- ADVB 2025
- Fundamental
- Price
- LXEH $1.40
- ADVB $0.66
- Analyst Decision
- LXEH
- ADVB
- Analyst Count
- LXEH 0
- ADVB 0
- Target Price
- LXEH N/A
- ADVB N/A
- AVG Volume (30 Days)
- LXEH 302.6K
- ADVB 149.1K
- Earning Date
- LXEH 04-30-2025
- ADVB 08-03-2025
- Dividend Yield
- LXEH N/A
- ADVB N/A
- EPS Growth
- LXEH N/A
- ADVB N/A
- EPS
- LXEH N/A
- ADVB N/A
- Revenue
- LXEH $4,493,795.00
- ADVB N/A
- Revenue This Year
- LXEH N/A
- ADVB N/A
- Revenue Next Year
- LXEH N/A
- ADVB N/A
- P/E Ratio
- LXEH N/A
- ADVB N/A
- Revenue Growth
- LXEH N/A
- ADVB N/A
- 52 Week Low
- LXEH $1.20
- ADVB $0.56
- 52 Week High
- LXEH $50.08
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- LXEH 34.46
- ADVB N/A
- Support Level
- LXEH $1.49
- ADVB N/A
- Resistance Level
- LXEH $1.85
- ADVB N/A
- Average True Range (ATR)
- LXEH 0.17
- ADVB 0.00
- MACD
- LXEH 0.09
- ADVB 0.00
- Stochastic Oscillator
- LXEH 25.13
- ADVB 0.00
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.